Trade Mark Journal No.2025/023 6 June 2025

WO0000001855289 (5)

Office of origin: United States of America

Date of International Registration:10 April 2025
Date of designation in the UK: 10 April 2025
Image for mark 1855289 TRILLIUM

International priority date claimed: 16 October 2024 (United States of America) (98804622)
Class 5
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use.

Ratio Therapeutics, Inc.

Representative: Nicole Gage Beck Reed Riden LLP, 155 Federal Street, Boston MA 02110, UNITED STATES OF AMERICA